Back to Gastroenterology
Gastroenterologyv2022 HiranoEvidence-Based

Index of Severity for Eosinophilic Esophagitis (I-SEE)

Classifies severity of eosinophilic esophagitis (EoE) using a comprehensive scoring system that evaluates symptoms, complications, inflammatory features, and fibrostenotic changes. The I-SEE was developed by a multidisciplinary international group of EoE experts to standardize disease severity assessment beyond eosinophil counts alone. This validated clinical tool helps guide practitioners in EoE management by providing standardized disease severity classification that correlates with clinical features, treatment response, and need for interventions such as dilation. The score evaluates multiple domains including symptom frequency, complications (food impaction, hospitalization), inflammatory features (edema, furrows, exudates, eosinophil counts), and fibrostenotic features (rings, strictures) to provide a comprehensive assessment of disease severity.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Index of Severity for Eosinophilic Esophagitis (I-SEE) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Symptoms (0-4) + Food impaction (0-4) + Hospitalization (0-4) + Perforation (0-15) + Malnutrition (0-15) + Persistent inflammation (0-15) + Inflammatory features (0-2) + Eosinophil count (0-2) + Rings/strictures (0-15)

Clinical Pearls & Practice Notes

  • Developed by multidisciplinary international group of EoE experts
  • Standardizes disease severity assessment beyond eosinophil counts alone
  • Inactive (0 points): No evidence of active disease
  • Mild (1-6 points): Minimal functional impact, standard therapy typically effective
  • Moderate (7-14 points): Significant disease activity, may require combination therapy
  • Severe (≥15 points): High disease burden, may require advanced therapies or dilation
  • Correlates with clinical features including BMI, symptom duration, and esophageal diameter
  • Predicts need for dilation at follow-up (C statistic: 0.81)
  • Severity improves with successful topical corticosteroid treatment
  • Can be completed at routine clinic visits to assess disease severity
  • Eosinophil count ≥15 eos/hpf required to define presence of active EoE
  • Inflammatory features assessed using abbreviated EREFS (edema, furrows, exudates)
  • Fibrostenotic features may require mechanical intervention for symptom relief
  • Score should be reassessed after treatment to monitor therapeutic response
  • Validated in both adult and pediatric EoE populations

Evidence & Literature Citations

  1. Hirano I, Aceves SS, Blanchard C, et al. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology. 2022 Jul;163(1):59-76.e16. doi: 10.1053/j.gastro.2022.02.048.
  2. Rank MA, Shaffer K, Campion J, et al. A newly proposed severity index for eosinophilic esophagitis is associated with baseline clinical features and successful treatment response. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2890-2897.e2. doi: 10.1016/j.cgh.2023.04.013.
  3. Stern E, Schoepfer A, Spechler SJ, et al. The Index of Severity for Eosinophilic Esophagitis (I-SEE) Reflects Longitudinal Clinicopathologic Changes in Children. J Pediatr Gastroenterol Nutr. 2023 Dec;77(6):743-749. doi: 10.1097/MPG.0000000000003928.

Score Interpretation Ranges

Inactive0 – 0 pts

Score 0 points

Mild1 – 6 pts

Score 1-6 points

Moderate7 – 14 pts

Score 7-14 points

Severe15 – 45 pts

Score ≥15 points

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.